Forte Long Term Debt To Capitalization from 2010 to 2025

FBRX Stock  USD 15.96  1.31  8.94%   
Forte Biosciences Long Term Debt To Capitalization yearly trend continues to be fairly stable with very little volatility. Long Term Debt To Capitalization is likely to outpace its year average in 2025. During the period from 2010 to 2025, Forte Biosciences Long Term Debt To Capitalization regression line of annual values had significance of  0.00001 and arithmetic mean of (2.28). View All Fundamentals
 
Long Term Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
(6.23)
Current Value
(5.92)
Quarterly Volatility
3.04388388
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Forte Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Forte Biosciences' main balance sheet or income statement drivers, such as Interest Income of 1.3 M, Depreciation And Amortization of 7.7 K or Interest Expense of 14.5 K, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 0.8. Forte financial statements analysis is a perfect complement when working with Forte Biosciences Valuation or Volatility modules.
  
Check out the analysis of Forte Biosciences Correlation against competitors.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Latest Forte Biosciences' Long Term Debt To Capitalization Growth Pattern

Below is the plot of the Long Term Debt To Capitalization of Forte Biosciences over the last few years. It is Forte Biosciences' Long Term Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Forte Biosciences' overall financial position and show how it may be relating to other accounts over time.
Long Term Debt To Capitalization10 Years Trend
Slightly volatile
   Long Term Debt To Capitalization   
       Timeline  

Forte Long Term Debt To Capitalization Regression Statistics

Arithmetic Mean(2.28)
Coefficient Of Variation(133.70)
Mean Deviation2.92
Median0.30
Standard Deviation3.04
Sample Variance9.27
Range6.8932
R-Value(0.87)
Mean Square Error2.37
R-Squared0.76
Significance0.00001
Slope(0.56)
Total Sum of Squares138.98

Forte Long Term Debt To Capitalization History

2025 -5.92
2024 -6.23
2019 -5.42
2018 0.31
2017 0.0485
2016 0.66

About Forte Biosciences Financial Statements

Forte Biosciences investors use historical fundamental indicators, such as Forte Biosciences' Long Term Debt To Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Forte Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Long Term Debt To Capitalization(6.23)(5.92)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.